This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Immune checkpoint inhibitors, drugs that can help make the immune system recognize and destroy cancer more aggressively, are one of the most important medicines in cancer treatment today. Merck’s Keytruda has been used against dozens of different cancers in millions of patients, making it the top-selling drug in the world, with over $25 billion in revenue in 2023.
The community pharmacy contractual framework in each UK nation must minimise the risk of individual contractors incurring a potential loss on the purchase of medicines, the Royal Pharmaceutical Society (RPS) has said. In response to the All-Party Parliamentary Group (APPG) on Pharmacy's call for written evidence on medicines shortages, the RPS warned pharmacy funding must […] The post Pharmacy contract must minimise risk of dispensing at a loss, MPs told appeared first on The Pharmacist.
Eleos Health, maker of a product that generates clinical notes from audio of behavioral health appointments, has raised $60 million on the bet that therapy is different enough from other health care that providers need entirely different software. The rise of large language models that can efficiently summarize text has fueled the rapid development of companies using the technology to take documentation burden off overworked clinicians.
The Institute of Chemical Technology (ICT Mumbai), under its flagship initiative, the Mumbai Biocluster, awarded its prestigious 2nd Dr K Anji Reddy Memorial Fellowship for Affordable Biopharmaceuticals to Dr Cyrus Poonawalla, Chairman, Serum Institute of India, a visionary entrepreneur, and founder of the Serum Institute of India, in recognition of his contributions to biopharmaceutical innovation and global healthcare.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Plant-based foods are center stage in the new scientific report from the Dietary Guidelines Advisory Committee (DGAC). The committee recommended that the 2025-2030 Dietary Guidelines “include more nutrient-dense plant-based meal and dietary recommendation options,” prioritize plant-based protein over animal protein, and center plain water, instead of dairy milk and soda, as a beverage of choice.
Several batches of Tesco, Asda, Almus and Bells cough syrup have been recalled after a customer complained of finding 'foreign material' in a bottle. After identifying that some bottles were contaminated, manufacturer Bells Healthcare has recalled several batches of the dextromethorphan hydrobromide BP containing products 'as a precautionary measure'.
113
113
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Several batches of Tesco, Asda, Almus and Bells cough syrup have been recalled after a customer complained of finding 'foreign material' in a bottle. After identifying that some bottles were contaminated, manufacturer Bells Healthcare has recalled several batches of the dextromethorphan hydrobromide BP containing products 'as a precautionary measure'.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! It’s cold outside and dry dry dry inside the office here at STAT headquarters. It’s so bad, I almost considered smearing beef tallow all over my face. (While drafting this newsletter, one editor already reached out asking me not to do this.
The pharmacy common ailments service in Wales saw 420,951 patients in the last 12 months, new figures from the Welsh Government have revealed. This brings the total number of people who have accessed the service since it launched in 2013 to almost 1.25m. The figures were shared in advance of a speech made in the […] The post Welsh common ailments service saw more than 400,000 patients last year appeared first on The Pharmacist.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I’m still recovering from yesterday, when Chicago was reportedly colder than Antarctica. I hope you’re all staying warm wherever you are. Let’s get into the news today.
Bhubaneswar based biotech startup Exsure has raised rupees three crores in a seed round led by Unicorn India Ventures. The funds raised will be used to complete the milestones of non-clinical study with its exosome-based drug delivery vehicle and will also support Exsures global expansion plan with its in-house manufactured R&D products and promote Exosure, Leucosure, PlantExosure and Dr Berries.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. You can find our updated counting below. As youll see below, the combination of formulary exclusion and private labels is creating an increasingly confusing and crowded biosimilar marketplace.
Strides Pharma Science announces that the company has received an ESG score of 76/100 and a CSA score of 75/100 in the Corporate Sustainability Assessment (CSA) Annual Review (vide report dated January 20, 2025) for its debut submission. Strides has secured a position in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry.
The Science Behind Generic Drug Bioequivalence: Separating Fact from Fiction As a healthcare professional or someone simply looking to stay informed, you've likely heard the term "bioequivalence" thrown around when it comes to generic drugs. But what does it really mean, and how does it impact the medications we take? Bioequivalence is a crucial concept in the world of pharmaceuticals, ensuring that generic versions of brand-name medications are just as effective as their original coun
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The Unseen Heroes of Generic Drug Manufacturing: Good Manufacturing Practice (GMP) As we navigate the complex world of generic drug manufacturing, it's easy to overlook the unsung heroes that ensure the quality and safety of these life-saving medications. I'm talking about Good Manufacturing Practice (GMP), a set of guidelines that govern the production, testing, and packaging of generic drugs.
The US Food and Drug Administration (FDA) has approved the first monotherapy for adults with treatment-resistant depression.Johnson & Johnsons SPRAVATO (esketamine) CIII nasal spray is indicated for major depressive disorder (MDD). Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceutical company.
A new and exclusive series set to be released over the coming weeks will explore how the ARRS has altered the pharmacy landscape both in practices and community settings while shining a light on the workforce issues facing both sectors In the past, GP practices mostly comprised doctors, nurses and administrative staff. But […] The post New series: Has the ARRS been a positive or a negative?
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Physicians today face mounting challenges as they work to maintain profitability amidst shrinking reimbursements, operational inefficiencies and limited resources. Balancing quality care with financial stability can be overwhelming but with targeted strategies, practices can navigate these obstacles and uncover new revenue opportunities. Understanding the Obstacles Declining reimbursement rates from Medicare and private payers make it increasingly difficult for practices to cover costs and remai
Takeda, a global biopharmaceutical company, is due to launch a project, INTERCEPT, which will use biomarkers to prevent symptomatic onset of Crohns Disease before the disease begins to affect patients, later in February. The trial is a first in Europe. The INTERCEPT project will recruit 10,000 healthy relatives of patients with Crohns Disease from seven […] The post Biomarkers used in trial to prevent systematic onset of Crohns Disease before it begins in Europe-first project appeared firs
Do you ever get those questions where you know you are correct but you have to check the literature? I believe I’ve come across this order once or twice in my career: oral lorazepam PRN for a seizure. Can this be done? Here are the details on why this shouldn’t be done. Can I give […] The post Oral Lorazepam PRN For A Seizure? Is This Right?
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
GP practices across England are struggling to recruit pharmacists because of local competition and issues related to pay, an exclusive report has suggested. The new white paper launched today by our publisher Cogora has laid bare the scale of the workforce crisis across general practice and explores where pharmacists sit within this. It comes after […] The post GP practices sound alarm over pharmacist recruitment struggles in new report appeared first on The Pharmacist.
Piramal Critcal Care (PCC), a division of Piramal Pharma, announced the US launch of Chlorpromazine Hydrochloride for Injecton, USP, which will be offered in 25mg/1mL and 50mg/2 mL vials. The launch of Chlorpromazine Hydrochloride for Injection, USP (25mg/1mL and 50mg/2 mL vials) is the latest in a series of recent product launches from Piramal Critical Care in the generic injectables market.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content